based on 20 analysts
60.00%
Buy
15.00%
Hold
25.00%
Sell
Based on 20 analysts offering long term price targets for Ipca Laboratories Ltd. An average target of ₹1591.05
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd price forecast by 20 analysts
Upside of3.10%
High
₹1970
Target
₹1591.05
Low
₹900
Ipca Laboratories Ltd target price ₹1591.05, a slight upside of 3.1% compared to current price of ₹1543.25. According to 20 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ipca Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:46.67%
Forecast
Actual
Including amortisation and stock based compensations
Ipca Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:160.69%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.48 % |
3 Month Return | -4.4 % |
1 Year Return | + 43.2 % |
Market Stats | |
Previous Close | ₹1,550.30 |
Open | ₹1,542.50 |
Volume | 1.75L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹39,152.90Cr |
P/E Ratio | 59.2 |
PEG Ratio | 8.89 |
Market Cap | ₹39,152.90 Cr |
P/B Ratio | 4.95 |
EPS | 20.86 |
Dividend Yield | 0.32 |
Sector | Pharmaceuticals |
ROE | 9.81 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹39,152.90 Cr | 30.62% | 0.58 | ₹529 Cr | ₹7,705 Cr | |
BUY | ₹12,523.02 Cr | -3.67% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹69,044.08 Cr | 28.8% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹1,00,085.06 Cr | 54.52% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹59,350.61 Cr | 24.18% | 0.53 | NA | NA |
Organisation | Ipca Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Ipca Laboratories Ltd
Ipca Laboratories Stock Shows Strong Upward Potential - 08 Jan, 2025
Ipca Laboratories Hits All-Time High Stock Price - 03 Jan, 2025
Ipca Laboratories Hits New Highs in January 2025 - 02 Jan, 2025
Ipca Laboratories Hits New High, Positive Analyst Outlook - 01 Jan, 2025
Ipca Laboratories Targeted for Growth and Revival - 30 Dec, 2024
Ipca Laboratories Shows Bullish Potential - 28 Dec, 2024
Ipca Laboratories Focuses on Sustained Earnings Growth - 24 Dec, 2024
IPCA Labs Anticipates Growth and Improved Margins - 23 Dec, 2024
IPCA Labs Sees Stake Sale Amid Stock Gains - 19 Dec, 2024
Ipca Laboratories Promoter Divests 1.6% Stake - 18 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 28.55% to 29.63% in Dec 2024 quarter
Price Rise
In the last 1 month, IPCALAB stock has moved up by 0.9%
Revenue Rich
Revenue is up for the last 3 quarters, 2.05K Cr → 2.38K Cr (in ₹), with an average increase of 7.1% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, 59.59 Cr → 229.48 Cr (in ₹), with an average increase of 42.6% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 10.83% to 11.07% in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 8.0%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 54.5%
Retail Holding Down
Retail Investor have decreased holdings from 8.64% to 8.53% in Dec 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 46.30% to 44.72% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.72% | ||
Foreign Institutions | 11.07% | 2.20 | |
Mutual Funds | 29.63% | 3.80 | |
Retail Investors | 8.53% | ||
Others | 6.04% | 6.46 |
Ipca Laboratories Ltd in the last 5 years
Lowest (18.72x)
October 10, 2019
Industry (54.95x)
January 17, 2025
Today (59.20x)
January 17, 2025
Highest (66.90x)
January 2, 2025
Ipca Laboratories Ltd’s net profit jumped 58.2% since last year same period to ₹229.48Cr in the Q2 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 19.37% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Ipca Laboratories Ltd has declared dividend of ₹2 - translating a dividend yield of 0.26%.
Read More about DividendsBearish
Neutral
Bullish
Ipca Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Ipca Laboratories Ltd share price today stands at ₹1543.25, Open. ₹1542.5 ; Previous Close. ₹1550.3 ; High. ₹1549 ; Low. ₹1528 ; 52 Week High. ₹1755.9 ; 52 Week Low: ₹1052.
Ipca Laboratories Ltd is listed on NSE
Ipca Laboratories Ltd is listed on BSE
PE Ratio of Ipca Laboratories Ltd is 59.2
PE ratio = Ipca Laboratories Ltd Market price per share / Ipca Laboratories Ltd Earnings per share
Today’s traded volume of Ipca Laboratories Ltd(IPCALAB) is 1.75L.
Today’s market capitalisation of Ipca Laboratories Ltd(IPCALAB) is ₹39152.9Cr.
Ipca Laboratories Ltd(IPCALAB | Price |
---|---|
52 Week High | ₹1755.9 |
52 Week Low | ₹1052 |
Ipca Laboratories Ltd(IPCALAB) share price is ₹1543.25. It is down -12.11% from its 52 Week High price of ₹1755.9
Ipca Laboratories Ltd(IPCALAB) share price is ₹1543.25. It is up 46.70% from its 52 Week Low price of ₹1052
Ipca Laboratories Ltd(IPCALAB | Returns |
---|---|
1 Day Returns | -7.05% |
1 Month Returns | -2.48% |
3 Month Returns | -4.4% |
1 Year Returns | 43.2% |